Parkwood LLC’s Insmed INSM Stock Holding History

Parkwood LLC’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-70,235	Closed	-$5.51M	–	116
2020 Q3	$5.51M	Buy	70,235 +60,888	+651%	+$1.75M	0.85%	40
2020 Q2	$257K	Buy	+9,347	New	+$222K	0.05%	90

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Parkwood LLC's INSM Position: Q4 2020 in Review

Parkwood LLC sold out of Insmed (INSM) in Q4 2020, closing a stake of 70,235 shares — an estimated $5.51M sold.

Parkwood LLC first reported a position in INSM in Q2 2020 and held it in 2 quarters. The position peaked at $5.51M in Q3 2020. 206 funds tracked by Wall St. Rank hold INSM as of Q4 2020.

Parkwood LLC reported no remaining Insmed position as of Q4 2020 after selling out during the quarter.
Parkwood LLC sold 70,235 Insmed shares in Q4 2020, an estimated $5.51M.
Parkwood LLC first reported a position in Insmed in Q2 2020 and held it in 2 quarters.
Parkwood LLC's Insmed position peaked at $5.51M in Q3 2020.
206 funds tracked by Wall St. Rank held Insmed as of Q4 2020.

Based on Parkwood LLC's 13F filing for Q4 2020, filed 12 Feb 2021.